BOLT
Price
$4.68
Change
-$0.43 (-8.41%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
9.82M
70 days until earnings call
Intraday BUY SELL Signals
MGNX
Price
$4.21
Change
+$0.16 (+3.95%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
257.43M
69 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BOLT vs MGNX

Header iconBOLT vs MGNX Comparison
Open Charts BOLT vs MGNXBanner chart's image
BOLT vs MGNX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BOLT vs. MGNX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLT is a Hold and MGNX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2026
Stock price -- (BOLT: $5.11 vs. MGNX: $4.05)
Brand notoriety: BOLT and MGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLT: 46% vs. MGNX: 46%
Market capitalization -- BOLT: $9.82M vs. MGNX: $257.43M
BOLT [@Biotechnology] is valued at $9.82M. MGNX’s [@Biotechnology] market capitalization is $257.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.89B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLT’s FA Score shows that 1 FA rating(s) are green whileMGNX’s FA Score has 0 green FA rating(s).

  • BOLT’s FA Score: 1 green, 4 red.
  • MGNX’s FA Score: 0 green, 5 red.
According to our system of comparison, BOLT is a better buy in the long-term than MGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLT’s TA Score shows that 4 TA indicator(s) are bullish while MGNX’s TA Score has 3 bullish TA indicator(s).

  • BOLT’s TA Score: 4 bullish, 4 bearish.
  • MGNX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BOLT is a better buy in the short-term than MGNX.

Price Growth

BOLT (@Biotechnology) experienced а -0.39% price change this week, while MGNX (@Biotechnology) price change was -9.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.54%. For the same industry, the average monthly price growth was -1.96%, and the average quarterly price growth was +3.26%.

Reported Earning Dates

BOLT is expected to report earnings on Aug 12, 2026.

MGNX is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Biotechnology (-1.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGNX($257M) has a higher market cap than BOLT($9.82M). MGNX YTD gains are higher at: 151.553 vs. BOLT (-6.545). BOLT has higher annual earnings (EBITDA): -43.24M vs. MGNX (-63.11M). MGNX has more cash in the bank: 146M vs. BOLT (31.9M). BOLT has less debt than MGNX: BOLT (23.6M) vs MGNX (37M). MGNX has higher revenues than BOLT: MGNX (126M) vs BOLT (5.2M).
BOLTMGNXBOLT / MGNX
Capitalization9.82M257M4%
EBITDA-43.24M-63.11M69%
Gain YTD-6.545151.553-4%
P/E RatioN/AN/A-
Revenue5.2M126M4%
Total Cash31.9M146M22%
Total Debt23.6M37M64%
FUNDAMENTALS RATINGS
MGNX: Fundamental Ratings
MGNX
OUTLOOK RATING
1..100
91
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
94
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BOLTMGNX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 7 days ago
74%
Bullish Trend 16 days ago
84%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BOLT
Daily Signal:
Gain/Loss:
MGNX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VECO61.033.78
+6.61%
Veeco Instruments
CYAB0.670.04
+5.56%
Cyabra Inc.
FTS54.750.29
+0.53%
Fortis
SCHL42.75-0.02
-0.05%
Scholastic Corp
OWLT5.25-0.24
-4.37%
Owlet